ANTHONY JONES: Open Payments
NPI 1841814803 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,801 in 114 payments from 20 companies in 2025. Trend: 2023 $1,933 · 2024 $2,654 · 2025 $2,801
Food & beverage: $2,672Education: $129
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $394 |
| Grifols USA, LLC | 9 | $330 |
| GlaxoSmithKline, LLC. | 16 | $311 |
| Amgen Inc. | 17 | $264 |
| Regeneron Healthcare Solutions, Inc. | 10 | $257 |
| CSL Behring | 8 | $232 |
| Genentech USA, Inc. | 5 | $154 |
| Galderma Laboratories, L.P. | 3 | $131 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
Products named: TEZSPIRE, DUPIXENT, Xembify, NUCALA, Xolair, NEMLUVIO, Andembry, NEFFY.
Industry payments across TN — which companies pay providers there.
